Prof Schmid speaks with ecancer at ESMO 2018 in Munich to discuss results from the IMpassion 130 trial of atezolizumab versus placebo in combinations with nab-paclitaxel to treat advanced and metastatic breast cancers. The experimental combination of PD1...
Original Article: Results from the IMpassion 130 trial treating metastatic breast cancer